Artemis Therapeutics Inc.
ATMS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $55 | $1 | $1 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $41 | $6 | $10 | $20 |
| Inventory | $47 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $143 | $7 | $11 | $22 |
| Property Plant & Equip (Net) | $87 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $35 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $122 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $265 | $7 | $11 | $22 |
| Liabilities | – | – | – | – |
| Payables | $571 | $0 | $0 | $0 |
| Short-Term Debt | $105 | $196 | $110 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $328 | $307 | $246 | $157 |
| Total Curr. Liab. | $1,004 | $503 | $356 | $157 |
| LT Debt | $251 | $0 | $0 | $103 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $36 | $0 | $0 | $0 |
| Total NC Liab. | $287 | $0 | $0 | $103 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,291 | $503 | $356 | $260 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,120 | $52 | $52 | $52 |
| Retained Earnings | -$2,365 | -$2,485 | -$2,318 | -$2,197 |
| AOCI | $37 | $0 | $0 | $0 |
| Other Equity | $182 | $1,937 | $1,921 | $1,907 |
| Total Equity | -$1,026 | -$496 | -$345 | -$238 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $265 | $7 | $11 | $22 |
| Net Debt | $301 | $195 | $109 | $101 |